Massmutual Trust CO Fsb Amicus Therapeutics, Inc. Transaction History

Massmutual Trust CO Fsb

$3.51 Billion
Q4 2024

A detailed history of Massmutual Trust CO Fsb transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 79 shares of FOLD stock, worth $759. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$759

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	BUY	$9.36 - $12.01 $739 - $948	79 New	79 $0
Q2 2024 Jul 02, 2024	BUY	$9.04 - $11.75 $2,467 - $3,207	273 Added 255.14%	380 $3,000
Q1 2024 Apr 09, 2024	BUY	$11.43 - $14.24 $331 - $412	29 Added 37.18%	107 $1,000
Q4 2023 Jan 03, 2024	BUY	$9.97 - $14.52 $777 - $1,132	78 New	78 $1,000
Q3 2018 Nov 09, 2018	SELL	$11.6 - $16.54 $3,480 - $4,962	-300 Closed	0 $0
Q1 2018 May 21, 2018	SELL	$13.76 - $17.12 $9,632 - $11,984	-700 Reduced 70.0%	300 $4.51 Million
Q4 2017 Mar 01, 2018	SELL	$12.51 - $16.24 $61,849 - $80,290	-4,944 Reduced 83.18%	1,000 $14.4 Million
Q4 2017 Feb 21, 2018	BUY	$12.51 - $16.24 $61,849 - $80,290	4,944 Added 494.4%	5,944 $379 Million
Q3 2017 Feb 13, 2018	BUY	$11.74 - $15.78 $11,740 - $15,780	1,000	1,000 $15.1 Million

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

312M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$277 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$270 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$234 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$230 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$223 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.

Account